Skip to content

Remote Access to Care, Everywhere, for Parkinson Disease

Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02144220
Acronym
RACE-PD
Enrollment
277
Registered
2014-05-21
Start date
2014-03-31
Completion date
2016-10-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Telemedicine, Virtual care visit, Remote visit, Video-conferencing

Brief summary

The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are: 1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally; 2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and 3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.

Interventions

OTHERVirtual care visit

Video-conferencing visit with a Parkinson disease specialist

Sponsors

Davis Phinney Foundation
CollaboratorOTHER
University of Rochester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* Age greater than 30 * Self reported diagnosis of idiopathic Parkinson disease * Ability to converse in English * Ability and willingness to provide informed consent and complete study requirements * Access to a non-public computer or similar devices with broadband internet. * Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.)

Exclusion criteria

* Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation. * Concurrent enrollment in another telemedicine study.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility6 monthsThe percent of telemedicine visits completed as scheduled. (Goal \>80%)
Change in Quality of Life as Measured by the PDQ-39 Assessment ToolBaseline and 6 monthsThe impact on Quality of life (QoL) as measured by the change in PDQ-39 score from baseline to 6 months. The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month. 5-point ordinal scoring system: 0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 = always. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.

Secondary

MeasureTime frameDescription
Acceptability6 months\- The percent of patients participated who stated that they are interested in receiving ongoing care for their PD via telemedicine. (Goal \>80%)
Feasibility (Descriptive)6 monthsPercentage of physician visits where the physician was were satisfied or very satisfied with the virtual visit overall.
Percentage of Patients Who Felt That the Recommendations Improved Their Health6 months

Countries

United States

Participant flow

Recruitment details

Recruitment was primarily online through mass email messaging from the Davis Phinney Foundation, internet listings on Fox Trial Finder, messages from PatientsLikeMe, Google AdWords in eligible states, and outreach to support groups.

Pre-assignment details

Individuals indicated their interest in participating by either visiting the Davis Phinney Foundation's funded research web page where individuals completed an online screening survey or by contacting study coordinators by phone or email.

Participants by arm

ArmCount
Virtual Care Visit
One-time virtual care visit for Parkinson disease. Virtual care visit: Video-conferencing visit with a Parkinson disease specialist
277
Total277

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLack of Efficacy4
Overall StudyPhysician Decision3
Overall StudyProtocol Violation1
Overall Studytechnology incompatibility9
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicVirtual Care Visit
Age, Continuous67.1 years
STANDARD_DEVIATION 9.1
Gender
Female
138 Participants
Gender
Male
139 Participants
Region of Enrollment
United States
277 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 277
serious
Total, serious adverse events
0 / 277

Outcome results

Primary

Change in Quality of Life as Measured by the PDQ-39 Assessment Tool

The impact on Quality of life (QoL) as measured by the change in PDQ-39 score from baseline to 6 months. The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month. 5-point ordinal scoring system: 0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 = always. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.

Time frame: Baseline and 6 months

ArmMeasureValue (NUMBER)
Virtual Care VisitChange in Quality of Life as Measured by the PDQ-39 Assessment Tool0.4 units on a scale
p-value: 0.39t-test, 2 sided
Primary

Feasibility

The percent of telemedicine visits completed as scheduled. (Goal \>80%)

Time frame: 6 months

ArmMeasureValue (NUMBER)
Virtual Care VisitFeasibility91 percentage of visits
Secondary

Acceptability

\- The percent of patients participated who stated that they are interested in receiving ongoing care for their PD via telemedicine. (Goal \>80%)

Time frame: 6 months

ArmMeasureValue (NUMBER)
Virtual Care VisitAcceptability74 percentage of participants
Secondary

Feasibility (Descriptive)

Percentage of physician visits where the physician was were satisfied or very satisfied with the virtual visit overall.

Time frame: 6 months

ArmMeasureValue (NUMBER)
Virtual Care VisitFeasibility (Descriptive)94 percentage of visits
Secondary

Percentage of Patients Who Felt That the Recommendations Improved Their Health

Time frame: 6 months

ArmMeasureValue (NUMBER)
Virtual Care VisitPercentage of Patients Who Felt That the Recommendations Improved Their Health56 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026